The bilateral trafficking of nucleated cells between the fetus and the mother was studied using polymerase chain reaction PCR)-based systems sensitive enough to detect 1 target cell in 100,000 background cells. Sixty-six mother-baby pairs were recruited; maternal and cord blood samples were collected at delivery for DNA extraction. Cell trafficking was studied in informative cases using PCR-genotyping of polymorphic regions in the p-globin cluster, the glutathione Stransferase M1 locus and the angiotensin converting enzyme gene. In addition, Y-PCR was also used in conjunction with these systemsfor the detection of fetal cells in maternal circulation. Fetal cells were detected in maternal peripheral HE FETAL and maternal circulations are separated by T the villous trophoblastic layers in the placenta. However, a number of studies have suggested that trafficking of cells can occur between the fetal and maternal circulations. The passage of fetal erythrocytes into maternal blood is probably the best studied aspect of this phenomenon, largely because of the clinical importance of rhesus sensitization and the development of the hemolytic disease of the newborn.' The passage of nucleated fetal cells into maternal circulation is a less well studied phenomenon but has been shown by the detection of cells with a male karyotype in maternal blood from mothers bearing male fetuses' and by the sorting of cells with patemally-inherited HLA antigens from maternal blood using the fluorescence activated cell sorter..' The reverse phenomenon involving the passage of maternal cells into fetal circulation is even less understood. There are several reports describing the detection of isotopically-and fluorescence-labeled maternal erythrocytes4 and leukocytes' in umbilical cord blood following their intravenous injection into the mother before delivery, and cells carrying the XX karyotype have been detected in the peripheral blood (PB) of a male baby with congenital abnormalities6 Whether this trafficking of maternal cells into the fetal circulation has any function is unknown. Clinically, the existence of maternal leukocytes in fetal blood may have consequences when umbilical cord blood is being used for bone marrow transplantation (BMT)7,8 and in the vertical transfer blood in 26 of 51 cases whereas maternal cells were detected in 16 of 38 fetal umbilical cord blood samples. The proportion of umbilical samples with detectable maternal sequences was much higher than previously reported. In the 28 cases informative for both mother and baby, there was no obvious correlation between the cell traffic from mother to baby as compared to that from baby to mother. These findings may have implications for the use of cord blood for bone marrow transplantation, the vertical transmission of infectious agents, and the physiology of the feto-maternal relationship.
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of infectious agents. The passage of maternal blood into fetal circulation has also been suggested as a possible mechanism for rhesus D sensitization, if rhesus D+ maternal red cells enter the circulation of a rhesus D-fetus.'." This possibility has been referred to as the "grandmother theory" by some
With the development of molecular biological techniques, especially since the advent of the polymerase chain reaction (PCR),13 powerful new tools are available to study the trafficking of cells between the mother and fetus. Hence, the PCR has been used successfully to detect fetal genetic sequences from maternal PB.I4 l7 In contrast, there have been very few studies using molecular techniques in detecting maternal cells or maternal DNA sequences in fetal
In this study we sought to detect maternal DNA sequences in fetal blood by using very sensitive PCR-based methods which are able to detect 1 maternal cell in 100,000 fetal cells (ie, 0.001%). In addition, we have also attempted to detect fetal DNA sequences in maternal blood using the same fetomaternal pairs. This systematic approach allows us to correlate the two-way trafficking in the same study population.
MATERIALS AND METHODS
Collection of maternal and umbilical cord blood samples. Pregnant women were recruited before delivery at the Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital (Oxford, UK). Ethics approval was obtained from the Central Oxford Research Ethics Committee (COREC no. 94.077). Informed consent was obtained in all cases. Fetal sex was noted at delivery. Immediately upon delivery, the umbilical cord was double clamped and transected from the umbilicus. The cord was cleaned carefully with saline, the Wharton's jelly was then peeled off and the cord rewashed with saline. Umbilical venous blood was then withdrawn between the two clamps using a needle and syringe into an EDTA-containing tube. Ten milliliters of maternal blood was collected from the antecubital fossa at delivery and stored in an EDTA-containing tube.
DNA was extracted from the mother's and baby's blood using a Nucleon DNA extraction kit from Scotlabs (Strathclyde, Scotland, UK) according to the manufacturer's recommendations.
The PCR was performed essentially as described by Saiki et al" using reagents obtained from a GeneAmp DNA Amplification Kit (Perkin Elmer, Foster City, CA). Primer sequences are listed in * Primers designed for current report using sequences from the EMBL database (accession no. X62855 and A28005).
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these three systems were used in conjunction with a fourth one involving the detection of Y-chromosomal sequences from a male fetus.
The first system was based on a highly polymorphic region 5' to the human &globin and P-globin genes.''." This 3.1-kb polymorphic region consisted of 18 polymorphic sites segregating as one of two haplotypes, termed the R and the T haplotype. For the detection of maternal DNA sequences in fetal blood, the mother should be heterozygous (ie, RT) and the baby should either be homozygous RR or 'IT. In the case of a homozygous RR baby, the detection step involved the detection of the maternal T allele. On the other hand, in the case of a homozygous 'IT baby, the detection step involved the detection of the maternal R allele. Analogous criteria also apply to the detection of fetal cells in maternal blood.
RT typing of the mother-baby pairs was performed by PCR amplification on 1 pg of the maternal or fetal DNA using the primer pair COMM639 and COMM1223 (see Table 1 ) using 40 cycles of 94°C for 1 minute, 57°C for 1 minute and 72°C for 1 minute. Mg2+ concentration was kept at 1.5 mmoVL. The PCR product could then be typed into the R or the T genotype by the detection of a Taq I site at position 1152 (numbering according to Maeda et a]' ' ), which was present in the T haplotype but not in the R haplotype. Ten microliters of the PCR products was then restricted in a total reaction volume of 20 pL in the presence of 10 U of Taq I (Boehringer Mannheim, East Sussex, UK) at 65°C for 2 hours. The restricted products were then analyzed by agarose gel electrophoresis.
Informative cases were then analysed using highly sensitive nested allele-specific PCR systems. For the detection of a matemal R allele in a homozygous 'IT baby or a fetal R allele in a homozygous 'IT mother, nested PCR using R-specific primers were used. The design of these allele-specific primers based on the amplification refractory mutation system (ARMS)" has been discussed elsewhere." R-specific amplification was achieved on 1 pg of umbilical cord blood or maternal DNA by performing 30 cycles of first round amplification using the primer pair ARMS757R and COMM1223 (94°C 1 minute, 55°C 1 minute, and 72°C 1 minute using a Mg'+ concentration of 4.0 "om, product size 516 bp). Two microliters of this first round product was then reamplified using a nested pair of primers ARMS894R and ARMS1154R (94°C 1 minute, 57°C 1 minute, and 72°C 1 minute for 30 cycles, using a Mg'+ concentration of 4.0 mmoVL, product size 319 hp).
For the detection of a maternal T allele in a homozygous RR baby or a fetal T allele in a homozyous RR mother, nested PCR using Tspecific primers were used. T-specific amplification was performed on 1 pg umbilical cord blood or maternal blood DNA using 30 cycles of first round amplification using the primer pair ARMS757T and ARMS1 154T (94°C 1 minute, 57°C 1 minute, and 72°C 1 minute using a Mg2+ concentration of 2.0 mmoVL, product size 447 bp). Two microliters of this first round product was then reamplified using a hemi-nested pair of primers ARMS757T and ARMS919T (94°C 1 minute, 57°C 1 minute, and 72°C 1 minute for 25 cycles, using a Mgz' concentration of 1.5 "om, product size 212 bp). The second system used for the study of two-way cell trafficking was based on the glutathione S-transferase M1 (GSTMl) ~OCUS.'~ This locus was polymorphic in that the GSTMl gene is deleted in approximately 50% of the population. Mother-baby pairs informative for this locus would have the mother possessing the GSTMl gene and the baby possessing the null allele or vice versa. Typing of the GSTMl status was performed using primers GSTMlE4 and GSTMlE5 (Table 1 )24 in 30 cycles of PCR (94°C 1 minute, 59°C 1 minute, and 72°C for 1 minute, Mg'+ concentration of 1.5 mmoU L). Amplification of individuals with a GSTMl gene would produce a 273-bp product which was absent in GSTMl null homozygotes. Umbilical cord blood or maternal blood DNA from informative cases was then subjected to a heminested GSTMl PCR of much higher sensitivity, to detect the rare maternal sequences in the baby's blood or fetal sequences in maternal blood. Thirty cycles of first round PCR were carried out using the primers GSTMlE4 and GSTMlES (thermal profile as above). Two microliters of first round product was then reamplified using the primers GSTMlES and GSTP3 for 30 cycles (94°C 1 minute, 59°C 1 minute, and 72°C for 1 minute, Mg'+ concentration of 1.5 mmol/L). The second round PCR product size was 252 bp.
The third system was based on the detection of the insertion/ deletion polymorphism at the angiotensin converting enzyme (ACE) gene." This polymorphism is because of the insertion or the deletion of a 287-bp fragment in intron 16 of the ACE gene. Typing of the ACE status was performed using primers ACE-PI and ACE-P2 (Table 1 ) using 30 cycles of PCR (94°C 1 minute, 58°C 1 minute, and 72°C 1 minute, Mg'+ concentration of 3 mmoVL). The insertion and deletion alleles were indicated by 479-hp and 191-bp PCR products, respectively.
For the detection of maternal sequences in fetal blood or fetal sequences in maternal blood, a nested strategy was used. For the high sensitivity detection of the insertion allele, a heminested system was designed involving a first round Ampliwax-mediated Hot Startz6 PCR using primers ACE-P3 and ACE-I1 (94°C 1 minute, 62°C 1 minute, and 72°C 1 minute, Mg'+ concentration of 1 mmoVL, product size 425 bp). Two microliters of first round product was then reamplified using Hot Start PCR employing the primers ACE-PI and ACE-I1 for a further 20 cycles (94°C 1 minute, 62°C 1 minute, and 72°C 1 minute, Mg2+ concentration of 2 mmol/L, PCR product size 356 bp). Primer ACE-I1 was designed to be specific for the insertion allele.
The high sensitivity detection of the deletion allele was performed using heminested PCR using primers ACE-PI and ACE-P4 (94°C 1 minute, 60°C 1 minute (2-step cycle), Mg2+ concentration of 3 mmol/L, 30 cycles, product size 226 bp) followed by a heminested
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round using ACE-P1 and ACE-P2 (94°C 1 minute, 60°C 1 minute (2-step cycle), MgZf concentration of 3 mmoVL, 20 cycles, product size 191 bp). Allele-specificity for the deletion allele was conferred by the digestion of the insertion allele using the restriction enzyme Taq I (10 U per pg genomic DNA for 2 hours at 65°C) (Boehringer Mannheim) before DNA amplification. Ten units of Taq I was also added during both the first and the second rounds of PCR to cleave any residual DNA containing the insertion allele and any PCR product amplified from the insertion allele.
The detection of Y-specific fetal sequence from maternal blood was performed as described using primers to a single copy Y sequence (DYS14).*7 Primers Y1.7 and Y1 .S are listed in Table 1 .
Forty cycles of Hot Start PCR using Ampliwax technology26 was used on 1 pg of maternal DNA (denaturation step of 94°C 1 minute and a combined reannealing/extension step of 57°C 1 minute; Mg2' concentration of 1.5 mmol/L). The Y-specific product was 198 bp.
Anticontamination measures. Great precaution was taken against PCR contamination. All of the previously published guidelines were adhered to.2R Three separate laboratory areas were used: ( l ) for the preparation of genomic DNA, (2) setting up of the PCR and (3) the analysis of PCR products. All PCR reactions were assembled in a Class I1 cabinet. Aerosol resistant pipette tips were used in all experiments. Multiple negative controls were used in all amplification experiments.
RESULTS
Genotyping of mother-baby pairs. Sixty-six motherbaby pairs were recruited in this study. RT genotyping revealed 16 informative cases in which the mother possessed an allele not present in the baby (Table 2) . GSTMl typing was performed on the remaining cases and revealed a further 8 informative cases. ACE genotyping was then performed on the remaining cases and revealed a further 14 informative cases. Thus, a total of 38 informative cases for the detection of maternal cells in fetal circulation were found using these three systems.
Detection of maternal DNA sequences in umbilical cord blood DNA. Umbilical cord blood DNA from the 38 cases informative for either the RT, GSTMl, or the ACE polymorphisms was subjected to nested PCR analysis for an allele which the mother possessed but which the baby did not. Serial dilutions of target DNA in 1 pg of nontarget DNA (eg, RR in 'IT DNA) indicated that each of the systems was able to detect the DNA equivalent of a single target cell in a background of 100 background cells, following the first round PCR. The sensitivity was increased to the detection of a single target cell in a background of 100,000 background cells following the nested amplification (Fig 1) . In total, of the 38 cases informative for the detection of maternal cells in fetal circulation, 16 gave a positive PCR signal (Table 2 and Fig 2) .
Detection of fetal sequences in maternal blood. Thirtysix male babies were delivered out of the 66 mother-baby pairs ( Table 2) . Serial dilutions of male DNA in 1 pg of female DNA indicated that the Hot Start DYS14 Y-PCR system reached single molecule sensitivity. Fetal-derived Y sequences were detected in 21 out of 36 cases (Fig 2C) . Of the remaining cases, 8 cases were informative for the RT polymorphism, 2 cases for the GSTMl polymorphism, and 5 cases for the ACE polymorphism. In total, these 4 systems chromosome from a male fetus detected by DYS14 PCR; +. presence of PCR signal; -,absence of PCR signal; the system used for detecting maternal cells in umbilical cord blood or fetal cells in maternal blood is indicated in brackets.
The baby had Down's syndrome.
For Correlation of materno-fetal and feto-maternal cell trafjcking. Twenty-eight cases were informative for both directions of trafficking (Table 3 ). There was no obvious correlation between the presence of maternal cells in fetal circulation and fetal cells in maternal circulation.
DISCUSSION
In this study we systematically investigated the two-way trafficking of cells between the mother and baby. The arm of the project that detected fetal DNA sequences in maternal blood confirms previous work by our group and others that this approach constitutes a potential avenue for noninvasive prenatal diagn~sis.'~~"~~" Thus, we were able to detect fetalderived DNA sequences in 26 out of 5 l cases (5 1%). Using a multicopy Y target'" might have increased the detection rate of fetal DNA but we chose the present system because of its comparable sensitivity to the RT, GSTM1, and ACE systems.
By virtue of the much higher sensitivity of the detection systems (0.001%) described in this report, we were able to show maternal DNA sequences in 16 out of 38 cases (42%) of the umbilical cord blood samples. This is a much higher figure than that described by Socie et allR ( I in 47 or 2.1%) and Hall et all9 ( I O in 49 or 20%). The minisatellite PCR system used by Socie et all8 had a sensitivity for detecting 0.1% to 1 % of maternal cells in umbilical cord blood.Ix This relatively low level of sensitivity was because of the nonselective nature of minisatellite PCR in that both the target (ie, the mother's) and the background (ie, the baby's) sequences were amplified together. Under these conditions. the large excess of the background sequences could easily out-compete the rare target sequences for amplification..'" This problem was overcome by the use of amplification strategies such as ARMS, which specifically amplified the target sequence but was refractory to the background. The report by Hall et ally described the use of fluorescence in situ hybridization which had a sensitivity of 0. I%." The sensitivity of this technique was limited by the practical difficulty of examining more than 1,000 cells per case.
Apart For personal use only. on November 16, 2017. by guest www.bloodjournal.org From Though the techniques we used in this study were not strictly quantitative, we were able to conclude that the number of maternal cells in fetal circulation was low, 1 nucleated cell in between 100 and 100,000 fetal cells being of maternal origin. This conclusion was deduced from the fact that none of the positive cases demonstrated a signal following the first round of PCR which had a sensitivity of 1 target cells in 100 target cells. The sensitivity was boostered to 1 in 100,000 following the second round PCR.
Amongst the 28 cases which were informative in both directions of transfer, 13 cases showed discordance in the presence of fetal cells in maternal blood and maternal cells in fetal blood. The apparent lack of correlation between the existence of maternal cells in fetal blood and the presence of fetal cells in matemal blood is interesting. The existence of a correlation would have been consistent with a simple passive transfer phenomenon at the time of delivery. However, the lack of such a correlation would be consistent with either an active cell transfer process, which might be operative in certain mother-baby pairs; or that the predominant time of cell trafficking in these cases was prenatal and the relative detectability of the maternal and fetal cells would be determined by their corresponding half-lives in the fetal and maternal circulations, respectively. To this end, it would be interesting to carry out a follow-up project to study the possible presence of maternal cells in fetal circulation prenatally, using cordocentesis samples from fetuses undergoing prenatal diagnostic investigations.
This study shows for the first time the two-way nucleated cell traffic between mother and fetus, opening up a new and important field for further investigation. The highly sensitive systems described here can also be used to study physiologic or pathologic conditions which may affect the trafficking of maternal cells into fetal circulation. For example, it would be possible to investigate how long the maternal cells would persist in the fetal circulation. This is especially interesting as recent data have suggested the persistence of fetal cells in the circulation of some women even decades after delive r~.~' It is potentially possible that maternal cells might also persist in some babies following delivery, resulting in a persistent chimeric state. Other factors that may be studied include the blood groups and HLA types of the mother and baby. Our findings might also explain the observation that certain individuals exhibit a degree of tolerance to the noninherited maternal HLA antigens (NIMA)3z as they may be exposed to maternal antigens in utero through the passage of maternal cells into fetal blood. The availability of sensitive methods to study the two-way cell passaging may allow one to answer this and other questions and thus shed more light into the feto-maternal relationship.
